Omalirel 150mg Injection

Omalirel 150mg Injection (Omalizumab) represents a breakthrough for patients whose allergies are not adequately controlled by standard inhalers or pills. It works by “sopping up” the IgE antibodies in your blood before they can attach to mast cells and trigger an allergic reaction. This unique mechanism helps calm the immune system’s overreaction to environmental triggers like pollen, dust mites, and pet dander.

Why Omalirel 150mg is a Global Choice

• Asthma Attack Prevention: Significantly reduces the rate of severe asthma flare-ups and hospitalizations in adults and children (6+ years).

• Hives Relief: For those with Chronic Spontaneous Urticaria, Omalirel can stop the itching and welts even when high-dose antihistamines have failed.

• Nasal Polyp Management: Helps shrink nasal polyps and improve symptoms like congestion and loss of smell in patients with chronic rhinosinusitis.

• Reliance Quality: Produced by Reliance Life Sciences, a leader in biosimilar technology, ensuring high-purity Omalizumab for consistent clinical results.

Clinical Administration & Cold-Chain Storage

1. Dosing Protocol: The dose (usually 150 mg to 375 mg) and frequency (every 2 or 4 weeks) are customized based on your body weight and baseline IgE levels.

2. Injection Method: Administered as a subcutaneous injection. For doses above 150 mg, the total volume is typically divided into two separate injection sites.

3. Medical Supervision: Due to the risk of anaphylaxis, the first few doses must be administered by a healthcare professional who can monitor for reactions.

4. Strict Cold-Chain: Must be stored in a refrigerator (2°C to 8°C). Do not freeze or expose to high heat.

FAQ :

References:

https://www.ncbi.nlm.nih.gov/books/NBK545183/

https://www.ema.europa.eu/en/documents/product-information/xolair-epar-product-information_en.pdf